BVSBioventus Inc.
$12.70+91% 1Y
$12.70
$6.5152 weeks$15.30
The financials
Bioventus Inc. by the numbers
Bioventus Inc. (BVS) reported revenue of $153M in Q2 2026 (quarter ended Jun 27, 2026), up 3.8% from the same quarter a year earlier. That came with a gross margin of 69% and net income of $33M (22% of revenue). For the full year FY2025, revenue was $568M (−0.9% year on year) and net income $23M. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $153M | $148M | +3.8% |
| Gross profit | $106M | $102M | +3.5% |
| Operating income | $19M | $18M | +4.1% |
| Net income | $33M | $7.5M | +348% |
| Diluted EPS | $0.47 | $0.11 | +327% |
Medical Devices
Ranks #18 of 51 by RyuScore